Login

Ventyx Biosciences, Inc. SEC Filings

Filed On Filing
15 May 2026 SCHEDULE 13G/A
14 May 2026 SCHEDULE 13G/A
14 May 2026 SCHEDULE 13G/A
16 Mar 2026 15-12G
06 Mar 2026 EFFECT
06 Mar 2026 EFFECT
05 Mar 2026 SCHEDULE 13D/A
04 Mar 2026 Form 4: Gonzales Roy, Senior VP, Finance

Returned 5,313 shares to the issuer · Disposed of 281,700 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Subramaniam Somu, Director

Returned 3,337,495 shares to the issuer · Disposed of 130,762 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: White William Richard, Director

Disposed of 249,882 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Moore Matthew Richard, Chief Operating Officer

Disposed of 465,000 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Cadoret-Manier Onaiza, Director

Disposed of 129,364 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Hulme Allison, Director

Disposed of 129,364 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Gujrathi Sheila, Director

Returned 130,000 shares to the issuer · Disposed of 1,131,072 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Nuss John, CHIEF SCIENTIFIC OFFICER

Returned 489,481 shares to the issuer · Disposed of 9,063 Restricted Stock Units (Disposition to Issuer) · Disposed of 1,307,604 Stock Option (right to buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Mohan Raju, Director

Returned 2,372,863 shares to the issuer · Disposed of 23,688 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,792,930 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 Form 4: Forman Mark S, Chief Medical Officer

Returned 6,000 shares to the issuer · Disposed of 435,000 Stock Option (Right to Buy) (Disposition to Issuer)

04 Mar 2026 S-8 POS
04 Mar 2026 S-8 POS
04 Mar 2026 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support